Three Programs, One Platform
Our pipeline consists of three therapeutic candidates, each addressing high-burden veterinary indications with limited effective treatment options.
Platform-Based Approach
Instead of single products, we develop a scalable EV technology platform capable of supporting multiple species and disease indications.
Equivex
Primary indication: Osteoarthritis
Other Indications: Tendon and ligament injuries, Chronic endometritis
Canivex
Primary indication: Osteoarthritis
Other Indications: Skin wounds
Felivex
Primary indication: Chronic Kidney Disease
Other Indications: Acute kidney injury, Feline gingivostomatitis
© 2026 Hydra Therapeutics. All rights reserved.
